Abstract
Aim:
To investigate the endogenous signaling pathways associated with high proliferation potential of breast cancer cells.
Methods:
Breast cancer cell lines LM-MCF-7 and MCF-7 with high and low proliferation capability were used. The promoter activity of fatty acid synthase (FASN) was examined using luciferase reporter gene assay. The expression level of FASN mRNA was measured using RT-PCR and real time PCR, respectively. The level of leukotriene B4 (LTB4) was determined with ELISA. The expression levels of 5-lipoxygenase (5-LOX) was analyzed using RT-PCR and Western blot, respectively. 5-Bromo-20-deoxyuridine (BrdU) incorporation assay was used to study the proliferation of LM-MCF-7 and MCF-7 cells.
Results:
The promoter activity of FASN was significantly higher in LM-MCF-7 cells than MCF-7 cells. Treatment of LM-MCF-7 cells with ERK1/2 inhibitor PD98059 (30–50 μmol/L) or LOX inhibitor NDGA (25 μmol/L) abolished the activation of FASN. Moreover, treatment of LM-MCF-7 cells with the specific 5-LOX inhibitor MK-886 (20–40 μmol/L) or 5-LOX siRNA (50–100 nmol/L) decreased the promoter activity of FASN. The level of LTB4, the final metabolite produced by 5-LOX, was significantly higher in LM-MCF-7 cells than MCF-7 cells. Administration of exogenous LTB4 (1–10 nmol/L) was able to stimulate the promoter activity of FASN in MCF-7 cells. Treatment of LM-MCF-7 cells with the FASN inhibitor cerulenin (10 μmol/L) reduced all the levels of p-ERK1/2, 5-LOX, and LTB4. Treatment of LM-MCF-7 cells with cerulenin, PD98059, or MK-886 abolished the proliferation. Administration of exogenous LTB4 (10 nmol/L) significantly increased BrdU incorporation in MCF-7 cells.
Conclusion:
These results suggest a novel positive feedback loop involving FASN/p-ERK1/2/5-LOX/LTB4/FASN contributes to the sustaining growth of breast cancer LM-MCF-7 cells.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Monod J, Jacob F . Teleonomic mechanisms in cellular metabolism, growth, and differentiation. Cold Spring Harb Symp Quant Biol 1961; 26: 389–401.
Wanzel M, Russ AC, Kleine-Kohlbrecher D, Colombo E, Pelicci PG, Eilers M . A ribosomal protein L23-nucleophosmin circuit coordinates Mizl function with cell growth. Nat Cell Biol 2008; 10: 1051–61.
Li H, Xu LL, Masuda K, Raymundo E, McLeod DG, Dobi A, et al. A feedback loop between the androgen receptor and a NEDD4-binding protein, PMEPA1, in prostate cancer cells. J Biol Chem 2008; 283: 28988–95.
Wang HQ, Altomare DA, Skele KL, Poulikakos PI, Kuhajda FP, Di Cristofano A, et al. Positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cells. Oncogene 2005; 24: 3574–82.
Rasola A, Fassetta M, De Bacco F, D'Alessandro L, Gramaglia D, Di Renzo MF, et al. A positive feedback loop between hepatocyte growth factor receptor and beta-catenin sustains colorectal cancer cell invasive growth. Oncogene 2007; 26: 1078–87.
You J, Mi D, Zhou X, Qiao L, Zhang H, Zhang X, et al. A positive feedback between activated extracellularly regulated kinase and cyclooxygenase/lipoxygenase maintains proliferation and migration of breast cancer cells. Endocrinology 2009; 150: 1607–17.
Kim D, Rath O, Kolch W, Cho KH . A hidden oncogenic positive feedback loop caused by crosstalk between Wnt and ERK pathways. Oncogene 2007; 26: 4571–9.
Vazquez-Martin A, Colomer R, Brunet J, Lupu R, Menendez JA . Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells. Cell Prolif 2008; 41: 59–85.
Cheng C, Yaffe MB, Sharp PA . A positive feedback loop couples Ras activation and CD44 alternative splicing. Genes Dev 2006; 20: 1715–20.
Estrada Y, Dong J, Ossowski L . Positive crosstalk between ERK and p38 in melanoma stimulates migration and in vivo proliferation. Pigment Cell Melanoma Res 2009; 22: 6676.
Bradley EW, Ruan MM, Vrable A, Oursler MJ . Pathway crosstalk between Ras/Raf and PI3K in promotion of M-CSF-induced MEK/ERK-mediated osteoclast survival. J Cell Biochem 2008; 104: 1439–51.
Hu T, Li C . Convergence between Wnt-beta-catenin and EGFR signaling in cancer. Mol Cancer 2010; 9: 236.
Zhou X, Liu Y, You J, Zhang H, Zhang X, Ye L . Myosin light-chain kinase contributes to the proliferation and migration of breast cancer cells through cross-talk with activated ERK1/2. Cancer Lett 2008; 270: 312–27.
Flavin R, Peluso S, Nguyen PL, Loda M . Fatty acid synthase as a potential therapeutic target in cancer. Future Oncol 2010; 6: 551–62.
Little JL, Kridel SJ . Fatty acid synthase activity in tumor cells. Subcell Biochem 2008; 49: 169–94.
Lupu R, Menendez JA . Pharmacological inhibitors of fatty acid synthase (FASN) — catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents? Curr Pharm Biotechnol 2006; 7: 483–93.
Maloberti PM, Duarte AB, Orlando UD, Pasqualini ME, Solano AR, Lopez-Otin C, et al. Functional interaction between acyl-CoA synthetase 4, lipooxygenases and cyclooxygenase-2 in the aggressive phenotype of breast cancer cells. PLoS One 2010; 5: e15540.
Catalano A, Procopio A . New aspects on the role of lipoxygenases in cancer progression. Histol Histopathol 2005; 20: 969–75.
Chen X, Sood S, Yang CS, Li N, Sun Z . Five-lipoxygenase pathway of arachidonic acid metabolism in carcino-genesis and cancer chemoprevention. Curr Cancer Drug Targets 2006; 6: 613–22.
Ihara A, Wada K, Yoneda M, Fujisawa N, Takahashi H, Nakajima A . Blockade of leukotriene B4 signaling pathway induces apoptosis and suppresses cell proliferation in colon cancer. J Pharmacol Sci 2007; 103: 24–32.
Ye LH, Wu LY, Guo W, Ma HT, Zhang XD . Screening of a sub-clone of human breast cancer cells with high metastasis potential. Zhonghua Yi Xue Za Zhi 2006; 86: 61–5.
Ye LH, You JC, Guo W, Xu SF, Wu LY, Qi RZ, et al. Investigation of discrepant proteins between two breast cancer cell lines with different metastatic abilities. Ai Zheng 2006; 25: 823–7.
Cui W, Zhang Y, Hu N, Shan C, Zhang S, Zhang W, et al. MiRNA-520b and miR-520e sensitize breast cancer cells to complement attack via directly targeting 3UTR of CD46. Cancer Biol Ther 2010; 10: 232–41.
Hayashi T, Nishiyama K, Shirahama T . Inhibition of 5-lipoxygenase pathway suppresses the growth of bladder cancer cells. Int J Urol 2006; 13: 1086–91.
Tong WG, Ding XZ, Talamonti MS, Bell RH, Adrian TE . LTB4 stimulates growth of human pancreatic cancer cells via MAPK and PI-3 kinase pathways. Biochem Biophys Res Commun 2005; 335: 949–56.
Sanchez-Galan E, Gomez-Hernandez A, Vidal C, Martin-Ventura JL, Blanco-Colio LM, Munoz-Garcia B, et al. Leukotriene B4 enhances the activity of nuclear factor-kappaB pathway through BLT1 and BLT2 receptors in atherosclerosis. Cardiovasc Res 2009; 81: 216–25.
Woo CH, You HJ, Cho SH, Eom YW, Chun JS, Yoo YJ, et al. Leukotriene B(4) stimulates Rac-ERK cascade to generate reactive oxygen species that mediates chemotaxis. J Biol Chem 2002; 277: 8572–8.
Kridel SJ, Lowther WT, Pemble CWt . Fatty acid synthase inhibitors: new directions for oncology. Expert Opin Investig Drugs 2007; 16: 1817–29.
Mashima T, Seimiya H, Tsuruo T . De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy. Br J Cancer 2009; 100: 1369–72.
Lupu R, Menendez JA . Targeting fatty acid synthase in breast and endometrial cancer: An alternative to selective estrogen receptor modulators? Endocrinology 2006; 147: 4056–66.
Yang YA, Han WF, Morin PJ, Chrest FJ, Pizer ES . Activation of fatty acid synthesis during neoplastic transformation: role of mitogen-activated protein kinase and phosphatidylinositol 3-kinase. Exp Cell Res 2002; 279: 80–90.
Menendez JA, Colomer R, Lupu R . Why does tumor-associated fatty acid synthase (oncogenic antigen-519) ignore dietary fatty acids? Med Hypotheses 2005; 64: 342–9.
Menna C, Olivieri F, Catalano A, Procopio A . Lipoxygenase inhibitors for cancer prevention: promises and risks. Curr Pharm Des 2010; 16: 725–33.
Avis I, Hong SH, Martinez A, Moody T, Choi YH, Trepel J, et al. Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions. FASEB J 2001; 15: 2007–9.
Wei N, Wang B, Zhang QY, Mi MT, Zhu JD, Yu XP, et al. Effects of different dietary fatty acids on the fatty acid compositions and the expression of lipid metabolic-related genes in mammary tumor tissues of rats. Nutr Cancer 2008; 60: 810–25.
Pidgeon GP, Lysaght J, Krishnamoorthy S, Reynolds JV, O'Byrne K, Nie D, et al. Lipoxygenase metabolism: roles in tumor progression and survival. Cancer Metastasis Rev 2007; 26: 503–24.
Steinmetz R, Wagoner HA, Zeng P, Hammond JR, Hannon TS, Meyers JL, et al. Mechanisms regulating the constitutive activation of the extracellular signal-regulated kinase (ERK) signaling pathway in ovarian cancer and the effect of ribonucleic acid interference for ERK1/2 on cancer cell proliferation. Mol Endocrinol 2004; 18: 2570–82.
Bachi AL, Kim FJ, Nonogaki S, Carneiro CR, Lopes JD, Jasiulionis MG, et al. Leukotriene B4 creates a favorable microenvironment for murine melanoma growth. Mol Cancer Res 2009; 7: 1417–24.
Shan C, Xu F, Zhang S, You J, You X, Qiu L, et al. Hepatitis B virus X protein promotes liver cell proliferation via a positive cascade loop involving arachidonic acid metabolism and p-ERK1/2. Cell Res 2010; 20: 563–75.
Acknowledgements
The authors thank Dr Qiang LIU (University of Saskatchewan, Canada) for providing plasmid of pFASN-WT-Luc. This work was supported in part by National Basic Research Program of China (973 Program, No 2007CB914802, 2007CB914804, and 2009CB521702), National Natural Scientific Foundation of China (No 81071623 and 30770826) and Tianjin Natural Scientific Foundation (No 08JCZDJC20700).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Hu, N., Li, Y., Zhao, Y. et al. A novel positive feedback loop involving FASN/p-ERK1/2/5-LOX/LTB4/FASN sustains high growth of breast cancer cells. Acta Pharmacol Sin 32, 921–929 (2011). https://doi.org/10.1038/aps.2011.40
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/aps.2011.40
Keywords
This article is cited by
-
Cerulenin suppresses ErbB2-overexpressing breast cancer by targeting ErbB2/PKM2 pathway
Medical Oncology (2022)
-
Anoikis resistant mediated by FASN promoted growth and metastasis of osteosarcoma
Cell Death & Disease (2019)
-
Effects of ginsenoside Re on rat jejunal contractility
Journal of Natural Medicines (2014)
